The Newest Pharma Stock in Town - InvestingChannel

The Newest Pharma Stock in Town


What a great way to start a new week yesterday… +1,233% in one trade! My first +1,000% win of the month.

Stocks like this have been HOT lately, and I’ve got another one on watch heading into today.

I expect to double my money… maybe even triple it!

Ticker Code Ticker Name Ticker Industry Price Change Average Volume (50)*
INO Inovio Pharmaceuticals Inc Biotechnology 1.25% 36,584,219
CODX Co-Diagnostics Inc Diagnostics & Research -5.81% 8,240,175
GNUS Genius Brands International Inc Entertainment -33.20% 61,975,266
SRNE Sorrento Therapeutics Inc Biotechnology 18.22% 47,610,262
MRNA Moderna Inc Biotechnology -2.52% 26,697,782
AMRH Ameri Holdings Inc Information Technology Services -8.38% 2,895,168
T AT&T Inc. Telecom Services 4.30% 35,248,605
MGM MGM Resorts International Resorts & Casinos 8.59% 30,182,698
BNGO BioNano Genomics Inc Diagnostics & Research 0.00% 8,146,765
BABA Alibaba Group Holding Ltd – ADR Internet Retail 0.44% 22,615,801
LK Luckin Coffee Inc – ADR Restaurants 15.80% 49,289,433
TGT Target Corporation Discount Stores 1.97% 5,880,907
EXPE Expedia Group Inc Travel Services 4.37% 4,926,458
ROST Ross Stores, Inc. Apparel Retail 3.70% 2,913,780
MRVL Marvell Technology Group Ltd. Semiconductors -2.69% 10,777,666
AMZN Amazon.com, Inc. Internet Retail 2.51% 4,196,270
TTWO TAKE-TWO INTERACTIVE SOFTWARE, INC Common Stock Electronic Gaming & Multimedia 5.35% 2,562,598
MRO Marathon Oil Corporation Oil & Gas E&P 26.10% 43,064,208
MCD Mcdonald’s Corp Restaurants 4.64% 3,981,583
O Realty Income Corp REIT – Retail 6.33% 3,377,542

Small-cap stocks which have stock options available to be traded on them have been sizzling over the past few weeks.

I’ve hit doubles (or more) on stocks under $10 which make what are known as “Supernova” moves driven by catalysts and short squeezes.

Prior to moves like this is when the REAL money gets into each trade.

I’m talking about fat cats with $100k or more to put into an option trade or $1M or more to put into a stock on the dark pools – that’s the activity which I analyze prior to pulling the trigger on a trade.

Wall Street doesn’t want me accessing the secret moves they make… While I do indeed make many of them, I bring a lot of those same trades to YOU as well!

Let’s dive right into one today… In the world of biotech, testing and bringing to market a vaccine which effectively treats COVID-19 is the headline which seemingly may create the next pharma-giant, and I would think the CEO of each biotech company wants their company at the top of the news.

Sorrento Therapeutics (NYSE: SRNE), is the latest stock to hit headlines in the race for an effective COVID-19 vaccine.

A couple of weeks ago, the company made a name for itself by announcing positive results from preclinical testing.

As you can see in the chart above, shares skyrocketed from $2.50/share to $10/share in two days. Since then, the options on SRNE have become more liquid and SRNE is seeing increased buying from hedge funds and deep-pocket traders.

Shown in green in the chart above is the 20-day simple moving average line, a support level which SRNE is quietly holding as of right now. You’ll also notice SRNE has seen increasing buying volume over the past two trading sessions…

Do you think something could be cooking here? I do, and for that exact reason I’ll be looking out for unusual call option sweeps around the 20-day simple moving average line and possible dark pool prints to come in an attempt to take advantage of what could be another parabolic move to the upside if a positive catalyst is released.

Let me know how you do today!

Yours for TrackStar trading,

Davis Martin
America’s #1 Premarket and Day Trader

P.S. Every single day this week I’ll be posting a brand new video lesson on this Twitter account. I’ll be covering tactics which have helped accelerate my trading in 2020, one day at a time. Follow this link.

Disclaimer: This is not investment advice. This article is for information purposes only and opinion-based on financial advisor data across a selection of websites. Investors should be cautious about any and all investments and are advised to conduct their own due diligence prior to making any investment decisions.

Related posts

Peers Reducing Beta in Uncertain Times

InvestingChannel

Can this Stock Ease Your Stress?

InvestingChannel

Advisors Looking East and Going for Gold

InvestingChannel

Market Showing Some Crox

InvestingChannel

Tech Earnings, Elections and Covid Oh My!

InvestingChannel

Commodities at the Forefront as Elections Loom

InvestingChannel